Ramon Perez-Tanoira
Overview
Explore the profile of Ramon Perez-Tanoira including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
63
Citations
480
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Seijas-Pereda L, Fernandez-Gonzalez P, Asare I, Asumang G, Frimpong E, Rescalvo-Casas C, et al.
Acta Parasitol
. 2025 Jan;
70(1):47.
PMID: 39873835
Purpose: Malaria remains a major global health challenge, particularly in sub-Saharan Africa and low- and middle-income countries (LMICs), contributing substantially to mortality and morbidity rates. In resource-limited settings, access to...
2.
Seijas-Pereda L, Koster P, Dashti A, Bailo B, Guadano-Procesi I, Rescalvo-Casas C, et al.
Microbes Infect
. 2024 Sep;
27(2):105422.
PMID: 39260820
The clinical significance of Blastocystis sp. remains to be fully elucidated. This study assesses whether Blastocystis subtype diversity can affect the outcome of the infection and the occurrence of clinical...
3.
Seijas-Pereda L, Carmena D, Rescalvo-Casas C, Hernando-Gozalo M, Prieto-Perez L, Cuadros-Gonzalez J, et al.
Trop Med Infect Dis
. 2024 Aug;
9(8).
PMID: 39195620
Gastrointestinal microorganism resistance and dissemination are increasing, partly due to international travel. This study investigated gastrointestinal colonisations and the acquisition of antimicrobial resistance (AMR) genes among international travellers moving between...
4.
Morata-Moreno N, Perez-Tanoira R, Del Campo-Balguerias A, Carrillo-Hermosilla F, Hernando-Gozalo M, Rescalvo-Casas C, et al.
Antibiotics (Basel)
. 2024 Jul;
13(7).
PMID: 39061291
The guanidine core has been one of the most studied functional groups in medicinal chemistry, and guanylation reactions are powerful tools for synthesizing this kind of compound. In this study,...
5.
Hernando-Gozalo M, Rescalvo-Casas C, Seijas-Pereda L, Cuadros-Gonzalez J, Perez-Tanoira R
Heliyon
. 2024 May;
10(10):e30742.
PMID: 38803946
Objectives: The main aim of this study was to compare the clinical outcomes of patients attended in our area with infection (CDI) (sustained cure, recurrence or death) in relation to...
6.
Fernandez-Gonzalez P, Seijas-Pereda L, Tefasmariam A, Balcha S, Fernandez-Zarzoso M, Onoda M, et al.
J Eur Acad Dermatol Venereol
. 2024 Feb;
38(7):e617-e619.
PMID: 38334189
No abstract available.
7.
Linares-Rufo M, Bermudez-Marval H, Garcia-Bertolin C, Santos-Galilea J, Balsa-Vazquez J, Perez-Tanoira R, et al.
Malar J
. 2024 Jan;
23(1):7.
PMID: 38178126
Background: In Spain, the risk of imported malaria has increased in recent years due to the rise in international travel and migration. Little is known about the knowledge, information sources,...
8.
Hernando-Gozalo M, Aguilera-Correa J, Rescalvo-Casas C, Seijas-Pereda L, Garcia-Bertolin C, de la Mata F, et al.
Front Cell Infect Microbiol
. 2023 Oct;
13:1203991.
PMID: 37886663
Introduction: Antimicrobial Resistance is a serious public health problem, which is aggravated by the ability of the microorganisms to form biofilms. Therefore, new therapeutic strategies need to be found, one...
9.
Seijas-Pereda L, Rescalvo-Casas C, Hernando-Gozalo M, Angmorkie-Eshun V, Agyei E, Adu-Gyamfi V, et al.
Antibiotics (Basel)
. 2023 Aug;
12(8).
PMID: 37627741
Low- and middle-income countries bear a disproportionate burden of antimicrobial resistance and often lack adequate surveillance due to a paucity of microbiological studies. In this 2022 study, our goal was...
10.
Rescalvo-Casas C, Perez-Tanoira R, Villegas R, Hernando-Gozalo M, Seijas-Pereda L, Perez-Garcia F, et al.
Trop Med Infect Dis
. 2023 Jul;
8(7).
PMID: 37505636
A limited number of longitudinal studies have examined the symptoms associated with long-COVID-19. We conducted an assessment of symptom onset, severity and patient recovery, and determined the percentage of patients...